The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global cancer therapeutics market is undergoing significant expansion, driven by the increasing incidence of breast and lung cancer and heightened investments in oncology research. Cancer therapeutics comprises a broad spectrum of treatments aimed at managing or curing cancer. Standard treatment metrics often include chemotherapy, radiation, immunotherapy, targeted therapy, hormone therapy, surgical procedures, and stem cell therapy. The primary objective of these strategies is to eliminate or manage cancer cells, alleviate symptoms, and enhance patient survival rates. Depending on the specific type and stage of cancer, along with the patient's general health, multiple treatment types are frequently combined to maximize therapeutic effectiveness.

Cancer Therapeutics Market Segmentation Analysis

The cancer therapeutics market analysis is segmented based on three key areas: therapy type, indication, and distribution channel.

By therapy type, the market encompasses chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapeutic categories. Chemotherapy represented the leading segment in 2024.

In terms of indications, the market is segmented across blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. Lung cancer held the largest market share in 2024.

Regarding distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies accounted for the largest share of the market in 2024.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities

According to the World Health Organization's media center, different types of cancer account for approximately 1 in every 6 deaths across the globe. In 2022, there were an estimated 20 million new cancer cases and 9.7 million associated deaths; this burden is projected to rise by about 77% by 2050, further straining health systems and communities. The American Cancer Society reports that 5–10% of all cancers are linked to inherited genes. Numerous genes associated with cancer predisposition have been identified. For instance, mutations in inherited cancer predisposition genes such as BRCA1 and BRCA2 significantly increase the risk of developing breast, ovarian, and prostate cancers. Breast cancer is widely regarded as the most prevalent cancer among women, with its incidence continuously rising worldwide due to risk factors like environmental impact, genetic susceptibility, hormone imbalances, and lifestyle changes. Furthermore, breast cancer is among the most prevalent cancers in the U.S.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications